Low Molecular Weight Heparin
Also written as LMWH.
She is started on low-molecular-weight heparin and warfarin.
What our notes say
- She is started on low-molecular-weight heparin and warfarin. (Internal Medicine (MBIM 4100) main exam, Paper One: 3 July 2019)
- Low molecular weight heparins are less likely to have this complication. (hematopathology — Past Paper Questions & Answers)
- Low Molecular Weight Heparin (LMWH — e.g., enoxaparin) acts predominantly on Factor Xa and is monitored by anti-Xa levels (Haemostasis & Coagulation: Platelet Function & Bleeding Disorders)
- | Heparin | Low-molecular-weight heparin | Prevents clots in admitted patients | Bleeding, low platelets | (Pneumonia)
- | Heparin | Low-molecular-weight heparin (enoxaparin) | Start at once; pregnancy and cancer; prophylaxis in hospital | Bleeding, low platelets | (DVT and Venous Thromboembolism (with Pulmonary Embolism))
- Enoxaparin: low molecular weight heparin, given subcutaneously. (Clinical Pharmacology I (MBPL 4400) main exam: 25 January 2023)
Study material on Low Molecular Weight Heparin
- DVT and Venous Thromboembolism (with Pulmonary Embolism)
- Internal Medicine (MBIM 4100) special/supplementary exam, Paper Two: 14 August 2019